Correction: Soluble AXL: a possible circulating biomarker for neurofibromatosis type 1 related tumor burden.
Main Author: | PLOS ONE Staff |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4363568?pdf=render |
Similar Items
-
Soluble AXL: a possible circulating biomarker for neurofibromatosis type 1 related tumor burden.
by: Gunnar Johansson, et al.
Published: (2014-01-01) -
Correction: Circulating Angiopoietin-2 and Its Soluble Receptor Tie-2 Concentrations Are Related to Renal Function in Two Population-Based Cohorts.
by: PLOS ONE Staff
Published: (2017-01-01) -
Correction: Possible influence of B chromosomes on genes included in immune response and parasite burden in Apodemus flavicollis.
by: PLOS ONE Staff
Published: (2015-01-01) -
Correction: Evaluating modified diets and dietary supplement therapies for reducing muscle lipid accumulation and improving muscle function in neurofibromatosis type 1 (NF1).
by: PLOS ONE Staff
Published: (2021-01-01) -
Correction: Attenuated Age-Impact on Systemic Inflammatory Markers in the Presence of a Metabolic Burden.
by: PLOS ONE Staff
Published: (2015-01-01)